WebBaird research teams are focused in industry sectors that we believe offer meaningful investment opportunities for our individual and institutional clients. Information on our … WebArcturus Therapeutics, Inc. is followed by the analysts listed above. Please note that any opinions, estimates or forecasts regarding Arcturus Therapeutics, Inc.'s performance …
ARGX - Approved Unique [119 Stock Analyst Price Targets]
WebMembers of the Jubilant team are attending American Association for Cancer Research this month to present on JBI-778, our novel brain-penetrant small molecule… Web4 nov. 2024 · Joel Beatty -- Baird -- Analyst "Terrific. Thank you. A question on the COMMAND study. Whenever we get more data on that from BMS, could you discuss what data points you'd be curious to look for?" Anil Kapur -- Executive Vice President of Corporate Strategy and Chief Commercial Officer boma in the bush polokwane
Analyst Coverage IGM Biosciences
Web13 mrt. 2024 · In a report released on March 8, Joel Beatty from Robert W. Baird maintained a Buy rating on TRACON Pharmaceuticals (TCON – Research Report), with a price target of $8.00.The company’s shares ... Web(Updated - June 4, 2024 5:12 AM EDT) Baird analyst Joel Beatty assumes coverage on Atreca Inc. (NASDAQ: BCEL) ... This is a premium only article. WebTop Analysts Based on 8 analyst s offering 12 month price targets for Ultragenyx Pharmaceutical Inc. Min Forecast $50.00 +33.87% Avg Forecast $79.13 +111.85% Max … gm diet 6th day